As suggested by Matsuo et al. [20], we also consider that IL-8 not only is as a cytokine whose concentration is increased only in metastatic pancreatic cancer but also is a special marker of pancreatic cancer. This evidence concerns the gene CXCL8 and familial pancreatic carcinoma.